Arcus Biosciences, Inc.Arcus Biosciences, Inc.Arcus Biosciences, Inc.

Arcus Biosciences, Inc.

No trades
See on Supercharts

RCUS fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology, and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
RCUS has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company